Gene · 10288
Papers2,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long-term immune changes after COVID-19 and the effect of BCG vaccination and latent infections on disease severity. | Clin Transl Immunology | 2025 | 40584929 | PubTator, text mining | PubMed |
| Ivy Leaf Dry Extract EA 575® Is a Potent Immunomodulator Acting on Dendritic Cells. | Pharmaceutics | 2025 | 40574085 | PubTator, text mining | PubMed |
| SPI1 upregulated LILRB2 to enhance the immunosuppressive phenotype of LPS-tolerant macrophages by inhibiting TLR8-mediated MyD88/NF-κB signaling. | Biol Direct | 2025 | 40551156 | PubTator, text mining | PubMed |
| Analysis of miR-10a and IFNG Expression Before and After Treatment for Chronic Schistosomiasis mansoni. | Parasite Immunol | 2025 | 40470838 | PubTator, text mining | PubMed |
| Physiological Oxygen Levels in the Microenvironment Program Ex Vivo-Generated Conventional Dendritic Cells Toward a Tolerogenic Phenotype. | Cells | 2025 | 40422239 | PubTator, text mining | PubMed |
| Extracellular vesicles from human semen induce unique tolerogenic phenotypes in vaginal dendritic cells and regulatory T lymphocytes. | Front Immunol | 2025 | 40421022 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies tRNA modification enzyme CTU2 as a novel tumor biomarker and its role in immune microenvironment. | Front Immunol | 2025 | 40375999 | PubTator, text mining | PubMed |
| LILR genotype imputation with attribute bagging (LIBAG): leukocyte immunoglobulin-like receptor copy number imputation system. | Front Immunol | 2025 | 40260241 | PubTator, text mining | PubMed |
| Analysis of the molecular mechanisms of ulcerative colitis and atherosclerosis by microarray data. | Sci Rep | 2025 | 40155679 | PubTator, text mining | PubMed |
| Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor Development. | Cancer Immunol Res | 2025 | 40145984 | PubTator, text mining | PubMed |
| Targeting leukocyte immunoglobulin‑like receptor B2 in the tumor microenvironment: A new treatment prospect for solid tumors (Review). | Oncol Lett | 2025 | 39990807 | PubTator, text mining | PubMed |
| Bidirectional Mendelian Randomization identifies plasma proteins associated with urticaria risk. | Arch Dermatol Res | 2025 | 39961865 | PubTator, text mining | PubMed |
| Colony-stimulating factor 3 and its receptor promote leukocyte immunoglobulin-like receptor B2 expression and ligands in gastric cancer. | World J Gastrointest Oncol | 2025 | 39958563 | PubTator, text mining | PubMed |
| Peripheral monocyte subsets are altered during gestation in oocyte donation pregnancy complicated with pre-eclampsia. | Scand J Immunol | 2025 | 39920890 | PubTator, text mining | PubMed |
| Effects of Hsa-miR-4741/LILRB2 on Senescence of Nucleus Pulposus Cells and Their Prognostic Values in Lumbar Disc Herniation. | J Invest Surg | 2025 | 39894455 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Accuracy of MiRNAs in Pancreatic Cancer: A Systematic Review and Meta-Analysis. | J Cell Mol Med | 2025 | 39855897 | PubTator, text mining | PubMed |
| Enhanced effect of the immunosuppressive soluble HLA-G2 homodimer by site-specific PEGylation. | Sci Rep | 2025 | 39833185 | PubTator, text mining | PubMed |
| Dual Roles of miR-10a-5p and miR-10b-5p as Tumor Suppressors and Oncogenes in Diverse Cancers. | Int J Mol Sci | 2025 | 39796267 | PubTator, text mining | PubMed |
| Elucidating the molecular association and potential mechanisms between psoriasis and atrial fibrillation through biomarker and immune infiltration analysis. | Arch Dermatol Res | 2025 | 39776247 | PubTator, text mining | PubMed |
| A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals. | Front Immunol | 2024 | 39691709 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10288/papers?page=4